Patient preferences for HIV/AIDS therapy - a discrete choice experiment

Health Economics Review

Volumn 3, Issue 1, 2013, Pages 1-8

  Mühlbacher, Axel C ^a,e   Stoll, Matthias ^b   Mahlich, Jörg ^c,d   Nübling, Matthias ^e  

^a Hochschule Neubrandenburg   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c JANSSEN CILAG GMBH   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e Empirical Consulting   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DEMOGRAPHY; DISCRETE CHOICE EXPERIMENT; DRUG EFFICACY; EMOTION; EMOTIONAL QUALITY OF LIFE; FACTORIAL ANALYSIS; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; ONLINE SYSTEM; PATIENT PREFERENCE; PHYSICAL CAPACITY; PHYSICAL QUALITY OF LIFE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUANTITATIVE STUDY; QUESTIONNAIRE; RISK REDUCTION; SCORING SYSTEM; SELF CARE; SOCIAL QUALITY OF LIFE; SOCIOECONOMICS; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS LOAD;

EID: 84971321433     PISSN: None     EISSN: 21911991     Source Type: Journal    
DOI: 10.1186/2191-1991-3-14     Document Type: Article

References (30)

1. Pichenot M, Deuffic-Burban S, Cuzin L, et al: Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials. HIV Med 2012, 13:148-155.
2. Thompson MA, Aberg JA, Hoy JF, et al: Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012, 308:387-402.
3. Case KK, Ghys PD, Gouws E, et al: Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ 2012, 90:831-838A.
4. Centers for Disease Control and Prevention (CDC): Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly Rep 1981, 30:250-252.
5. th 2013.
6. World Health Organization (WHO): Adherence to long term therapies - evidence for action. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf, 2003, downloaded on May 3rd 2012.
7. Grierson J, Koelmeyer RL, Smith A, et al: Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med 2011, 12:562-569.
8. th 2013.
9. Nübling M, Andersen H, Mühlbacher AC: Entwicklung eines Verfahrens zur Berechnung der körperlichen und psychischen Summenskalen auf Basis der SOEP - Version des SF 12 (Algorithmus). Data Documentation 16. Berlin: Deutsches Institut für Wirtschaftsforschung (DIW); 2006. http://www.diw.de/documents/publikationen/73/diw_01.c.56544.de/diw_sp0006.pdf, downloaded on May 3rd 2012.
10. Train K: Discrete choice methods with simulation. Cambridge: Univ. Press; 2003.
11. Heidbrink M: Reliabilität und Validität von Verfahren der Präferenzmessung. Ein meta-analytischer Vergleich verschiedener Verfahren der Conjoint-Analyse. Universität Münster, Dissertation; 2006. https://miami.uni-muenster.de/ servlets/DerivateServlet/Derivate-3827/diss_heidbrink.pdf, downloaded on May 3rd 2012.
12. Bridges J, Onukwugha E, Johnson F, et al: Patient preference methods-a patient centered evaluation paradigm. ISPOR Connections 2007, 13:4-7.
13. Lancaster KJ: A new approach to consumer theory. Journal of Political Economy 1966, 74:132-157.
14. McFadden D: Conditional logit analysis of qualitative choice behavior. In Frontiers in Economics. Edited by Zarembka P. New York: Academic Press; 1974.
15. Ben-Akiva ME, Lerman SR: Discrete choice analysis: theory and application to travel demand. Cambridge: MIT Press; 1985.
16. Mühlbacher AC, Juhnke C, Bethge S: Experts' judgment on patient-centered coordinated care. Value Health 2010, 13(7):A337.
17. Telser H: Nutzenmessung im Gesundheitswesen: Die Methode der Discrete-Choice-Experimente. Hamburg: Kovac; 2002.
18. Street DJ, Burgess L: The construction of optimal stated choice experiments, theory and methods. New Jersey: Wiley; 2007.
19. Bradley M: User's Manual for SPEED Version 2.1 Stated preference experiment editor and designer. Hague Consulting Group: Hague; 1991.
20. Louviere JJ, Hensher DA, Swait JD: Stated choice methods: analysis and application. Cambridge: Univ. Press; 2000.
21. Hensher DA, Rose JM, Greene WH: Applied choice analysis: a primer. Cambridge: Univ. Press; 2005.
22. Bridges JF, Kinter ET, Kidane L, et al: Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982-2007. Patient 2008, 1:273-282.
23. Ryan M, Gerard K, Amaya-Amaya M: Using discrete choice experiments to value health and health care. Dordrecht: Springer; 2008.
24. Lancsar E, Louviere J, Flynn T: Several methods to investigate relative attribute impact in stated preference experiments. Soc Sci Med 2007, 64:1738-1753.
25. Jansen K, Brockmeyer NH, Hahn M, et al: Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German competence network for HIV/AIDS. Eur J Med Res 2009, 14:415-425.
26. KompNet HIV/AIDS: Kompetenznetz HIV/AIDS. Aktuelle Daten.; 2012. http://www. kompetenznetz-hiv.de/projekte/1180.htm, downloaded on May 3rd 2012.
27. Stone VE, Jordan J, Tolson J, et al: Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr 2004, 36:808-816.
28. Beusterien KM, Dziekan K, Flood E, et al: Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment. Value Health 2005, 8:453-461.
29. Bätzing-Feigenbaum J, Kollan C, Kühne A, et al: Cohort profile: the German ClinSurv HIV project - a multicentre open clinical cohort study supplementing national HIV surveillance. HIV Med 2011, 12:269-278.
30. Robert-Koch-Institut (RKI): HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Epidemiologisches Bulletin 2011, 21:172-198.